United States Gastric Cancer Diagnostic Procedure Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. United States Gastric Cancer Diagnostic Procedure Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. United States Gastric Cancer Diagnostic Procedure Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. United States Gastric Cancer Diagnostic Procedure Market Regional Analysis

6.2 United States Gastric Cancer Diagnostic Procedure Market Revenue 2020-2028 (US$ Million)

6.3 United States Gastric Cancer Diagnostic Procedure Market Forecast Analysis

7. United States Gastric Cancer Diagnostic Procedure Market Analysis – by Healthcare Providers

7.1 Diagnostic Laboratories

7.1.1 Overview
7.1.2 Diagnostic Laboratories: United States Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.2 Hospitals

7.2.1 Overview
7.2.2 Hospitals: United States Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.3 Cancer Research Institutes

7.3.1 Overview
7.3.2 Cancer Research Institutes: United States Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.4 Oncology Specialty Clinics

7.4.1 Overview
7.4.2 Oncology Specialty Clinics: United States Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. United States Gastric Cancer Diagnostic Procedure Market Analysis – by Symptom Types

8.1 Symptomatic and Asymptomatic

8.1.1 Overview
8.1.2 Symptomatic and Asymptomatic: United States Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. United States Gastric Cancer Diagnostic Procedure Market Analysis – by Body Fluid

9.1 Blood

9.1.1 Overview
9.1.2 Blood: United States Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.2 Urine

9.2.1 Overview
9.2.2 Urine: United States Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.3 Saliva

9.3.1 Overview
9.3.2 Saliva: United States Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.4 Stomach Wash/Gastric Juice

9.4.1 Overview
9.4.2 Stomach Wash/Gastric Juice: United States Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.5 Tissue

9.5.1 Overview
9.5.2 Tissue: United States Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. United States Gastric Cancer Diagnostic Procedure Market Analysis – by Procedures

10.1 Endoscopic Procedures

10.1.1 Overview
10.1.2 Endoscopic Procedures: United States Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.2 Biopsy & Tissue Tests

10.2.1 Overview
10.2.2 Biopsy & Tissue Tests: United States Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.3 Lab Tests

10.3.1 Overview
10.3.2 Lab Tests: United States Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.4 In-Vitro Diagnostic Tests

10.4.1 Overview
10.4.2 In-Vitro Diagnostic Tests: United States Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.5 Imaging Tests

10.5.1 Overview
10.5.2 Imaging Tests: United States Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.6 Molecular Diagnostics

10.6.1 Overview
10.6.2 Molecular Diagnostics: United States Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.7 Multiplexing Molecular Diagnostics & Immunoassays

10.7.1 Overview
10.7.2 Multiplexing Molecular Diagnostics & Immunoassays: United States Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

11. United States Gastric Cancer Diagnostic Procedure Market – United States Analysis

11.1 Overview

11.2 United States

11.2.1 United States Gastric Cancer Diagnostic Procedure Market Breakdown, by Key Country, 2023 and 2028 (%)
11.2.1.1 United States Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast Analysis – by Country
11.2.1.1 United States : United States Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.1.1 United States : United States Gastric Cancer Diagnostic Procedure Market Breakdown, by Healthcare Providers
11.2.1.1.2 United States : United States Gastric Cancer Diagnostic Procedure Market Breakdown, by Symptom Types
11.2.1.1.3 United States : United States Gastric Cancer Diagnostic Procedure Market Breakdown, by Body Fluid
11.2.1.1.4 United States : United States Gastric Cancer Diagnostic Procedure Market Breakdown, by Procedures

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Atlas-Link Biotech Co Ltd

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Bio-Rad Laboratories Inc

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 MiRXES Pte Ltd

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Agilent Technologies Inc

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 F. Hoffmann-La Roche Ltd

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 bioMerieux SA

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Thermo Fisher Scientific Inc

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Illumina Inc

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Vela Diagnostics Holding Pte Ltd

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Myraid Genetics Inc.

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

United States Gastric Cancer Diagnostic Procedure Market